George Mason University breast cancer treatment patent licensed by Targeted Pharmaceuticals
IMAGE: Dr. Virginia Espina, a science research associate professor of the Center for Applied Proteomics and Molecular Medicine (CAPMM) at George Mason University’s Institute of Biohealth Innovation. view more Credit: Copyright: www.gmu.edu Manassas, Va. – A patent granted to George Mason University Research Foundation Inc., which describes a novel treatment method for pre-invasive breast cancer, has…
Details